Technology | Cardiac PACS | February 13, 2019

Philips Launches Latest Iteration of IntelliSpace Cardiovascular at HIMSS 2019

Cardiac image and information management solution features new pediatric workflow and integration with Philips Forcare for enhanced interoperability across health systems and hospitals

Philips Launches Latest Iteration of IntelliSpace Cardiovascular at HIMSS 2019

February 13, 2019 — Philips announced the launch of IntelliSpace Cardiovascular 4.1, its next-generation cardiovascular image and information management system. The latest version builds on the existing pediatric reporting capabilities, recognizing the important and unique nature of the pediatric environment. Clinicians can now complete their workflows more efficiently in a web browser, while integration with Philips Forcare enables the sharing of patient data between health systems and hospitals. New features also include enhanced security, enterprise protocols and seamless access to Philips' QLab and Tomtec software tools.

In order to capture a complete view of a patient's condition, clinicians need to search across multiple programs, systems and healthcare institutions for specific information, like previous test results. IntelliSpace Cardiovascular 4.1 aggregates patient information into one solution to provide a holistic view to facilitate better informed decision-making, while delivering on the quadruple aim of improved patient and staff experience, better health outcomes and lower costs of care.

"With IntelliSpace Cardiovascular, we now have a much more integrated application where cardiology talks to radiology," said John Hayes, head of IT, Blackrock Clinic, Dublin, Ireland. "The integration with our patient management system and remote access means our internal workflows are more efficient and the housekeeping for the applications is far better."

Building on existing browser-based reporting capabilities for adult stress echocardiogram tests, the addition of the web-based pediatric module to IntelliSpace Cardiovascular 4.1 provides a complete echo solution that aggregates data into one system. The pediatric module also includes new z-score packages, which are a common way to chart serial measurements in pediatric cardiology practices. The new z-scores provide clinicians with the most up-to-date information to respond to patients more quickly to help improve care delivery. Through deep integration with Philips Forcare, which provides open-standards-based interoperability software, IntelliSpace Cardiovascular 4.1 enables the seamless and secure sharing of patient data across systems and hospitals in near real-time.

IntelliSpace Cardiovascular is available globally. In North America and other select markets, Philips IntelliSpace Cardiovascular is also available as part of IntelliSpace Enterprise Edition, Philips' next-generation enterprise-wide health informatics platform, which combines Philips IntelliSpace Radiology and Cardiology portfolios, as well as PerformanceBridge, Oncology Informatics, IntelliSpace Genomics and IntelliSpace Exchange.

IntelliSpace Cardiovascular will be spotlighted at the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and exhibition, Feb. 11-15 in Orlando, Fla.

For more information: www.usa.philips.com/healthcare

Related Content

CT imaging radiation dose tracking software from Imalogix displayed at RSNA 2019.

CT imaging radiation dose tracking software from Imalogix displayed at RSNA 2019. Photo by Dave Fornell.

Feature | Radiation Dose Management | March 04, 2021 | By Dave Fornell
More than a decade ago, there was an alarming, rapid rise in ionizing radiation exposure in the U.S.
GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

Feature | Ultrasound Imaging | March 04, 2021 | By Dave Fornell, Editor
Recent advances in ultrasound image sy...
Philips and The Walt Disney Company EMEA announced they are teaming up to test the effects of custom-made animation, including specially-made Disney stories, within Philips Ambient Experience, a solution that integrates architecture, design and enabling technologies, such as dynamic lighting, video projections and sound, to allow patients and staff to personalize their environment to create a relaxing atmosphere

Study will explore the effects and use of animated stories and characters, including Disney favorites, as part of Philips Ambient Experience solution.

News | Magnetic Resonance Imaging (MRI) | March 03, 2021
March 3, 2021 — ...
Researchers said women who skip even one scheduled mammography screening before a breast cancer diagnosis face a significantly higher risk of dying from the cancer.

Getty Images

News | Mammography | March 03, 2021
March 3, 2021 — Attendance at regular ...
Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
News | Contrast Media Injectors | February 25, 2021
February 25, 2021 — Guerbet announced the launch of ...
An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents. 

An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents. 

News | Cardio-oncology | February 25, 2021
February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMC